Phreesia Inc (PHR)

Currency in USD
9.33
-0.21(-2.20%)
Real-time Data·
PHR is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
9.309.50
52 wk Range
7.7732.76
Key Statistics
Prev. Close
9.54
Open
9.5
Day's Range
9.3-9.5
52 wk Range
7.77-32.76
Volume
291.46K
Average Volume (3m)
2.01M
1-Year Change
-65.1996%
Book Value / Share
5.91
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
PHR Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
14.28
Upside
+53.03%
Members' Sentiments
Bearish
Bullish
ProTips
5 analysts have revised their earnings upwards for the upcoming period

Phreesia Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

Analyst Ratings

12 Buy
8 Hold
0 Sell
Ratings:
20 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 14.28
(+53.03% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
Citizens
Hold---MaintainMay 29, 2026
Piper Sandler
Hold12.00+28.48%23.00DowngradeMay 28, 2026
DA Davidson
Buy14.00+49.89%14.00MaintainMay 28, 2026
Truist Securities
Hold12.00+28.48%11.00MaintainMay 28, 2026
Canaccord
Buy16.00+71.31%22.00MaintainMay 28, 2026

Phreesia Inc SWOT Analysis


Digital Health Pionee
Explore Phreesia's multifaceted platform revolutionizing patient engagement, administrative efficiency, and pharmaceutical marketing in the evolving healthcare IT landscape
Financial Momentum
Delve into Phreesia's impressive revenue growth, improving profitability metrics, and transition to positive adjusted EBITDA and free cash flow generation
Strategic Expansion
Learn how Phreesia's partnerships with large specialty provider networks and diverse revenue streams are driving scalability and market penetration
Market Outlook
Analyst price targets range from $34 to $35, reflecting confidence in Phreesia's growth potential and its positioning as a "growth-at-a-reasonable-price" opportunity
Read full SWOT analysis

Phreesia Inc Earnings Call Summary for Q1/2027

  • Phreesia reported Q1 FY2027 EPS of $0.05, beating estimates by 400%; revenue rose 13% YoY to $130.9M, stock climbed 2.01% after-hours.
  • Company achieved third consecutive quarter of positive net income at $3.0M, reversing prior year's $3.9M loss with improved efficiency.
  • Adjusted EBITDA surged 46.6% YoY to $30.5M with margin expanding to 23%; payment solutions revenue jumped 40% year-over-year.
  • Management projects Q2 FY2027 EPS of $0.31 and full-year EPS of $1.46, with Q2 revenue forecast at $129.45M indicating sustained growth.
  • Free cash flow improved $8.9M YoY to $16.4M; executives cite AccessOne integration and payment segment expansion as key growth drivers.
Last Updated: 2026-05-27, 05:46 p/m
Read Full Transcript

Earnings

Latest Release
May 27, 2026
EPS / Forecast
0.05 / 0.01
Revenue / Forecast
130.94M / 130.08M
EPS Revisions
Last 90 days

PHR Income Statement

Compare PHR to Peers and Sector

Metrics to compare
PHR
Peers
Sector
Relationship
P/E Ratio
62.9x5.0x−0.5x
PEG Ratio
0.530.000.00
Price/Book
1.6x1.4x2.6x
Price / LTM Sales
1.2x0.9x3.0x
Upside (Analyst Target)
46.8%54.6%58.6%
Fair Value Upside
Unlock42.6%10.2%Unlock

Phreesia, Inc. provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. It offers solutions including appointment optimization and referral management using AI-enabled workflows; and AI-based smart answering solution patient communications supported by voice and messaging solutions; integrated payment solutions embedded in intake and post-visit workflows, and financing solutions that enable healthcare organizations to accelerate cash collections while offering flexible payment options to patients; and digital intake and clinical data capture, patient engagement and activation tools, and measurement and analytics solutions. It also offers PhreesiaPads, a self-service intake tablets; and Arrivals Kiosks, which are on-site kiosks. The company serves a range of healthcare organizations including ambulatory practices, health systems, and hospitals, as well as life sciences companies, government entities, patient advocacy, public interest and not-for-profit and other organizations. Phreesia, Inc. was incorporated in 2005 and is based in Wilmington, Delaware.

Employees
1789

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
20.19M32.66%192.59M
Other Institutional Investors
41.94M67.34%400.11M
Public Companies & Retail Investors
0.000.00%0.00
Total
62.13M100.00%592.7M

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Pale Fire Capital SE14.44%8,924,32985,138
BlackRock, Inc.9.58%5,920,46956,481

People Also Watch

22.76
BRZE
-0.65%
23.87
WRBY
+5.04%
5.17
OPRX
+1.08%
48.21
WK
-1.88%
5.64
TASK
-1.83%

FAQ

What Is the Phreesia (PHR) Stock Price Today?

The Phreesia stock price today is 9.33 USD.

What Stock Exchange Does Phreesia Trade On?

Phreesia is listed and trades on the New York Stock Exchange.

What Is the Stock Symbol for Phreesia?

The stock symbol for Phreesia is "PHR."

What Is the Phreesia Market Cap?

As of today, Phreesia market cap is 576.09M USD.

What Is Phreesia's Earnings Per Share (TTM)?

The Phreesia EPS (TTM) is 0.15.

When Is the Next Phreesia Earnings Date?

Phreesia will release its next earnings report on Sep 09, 2026.

From a Technical Analysis Perspective, Is PHR a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Sell.

How Many Times Has Phreesia Stock Split?

Phreesia has split 0 times.

How Many Employees Does Phreesia Have?

Phreesia has 1789 employees.

What is the current trading status of Phreesia (PHR)?

As of Jun 08, 2026, Phreesia (PHR) is trading at a price of 9.33 USD, with a previous close of 9.54 USD. The stock has fluctuated within a day range of 9.30 USD to 9.50 USD, while its 52-week range spans from 7.77 USD to 32.76 USD.

What Is Phreesia (PHR) Price Target According to Analysts?

The average 12-month price target for Phreesia is 14.28 USD, with a high estimate of 20 USD and a low estimate of 9 USD. 12 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Buy. The stock has an +53.03% Upside potential.

What Is the PHR Premarket Price?

PHR's last pre-market stock price is 9.62 USD. The pre-market share volume is 80.00, and the stock has decreased by 0.08, or 0.84%.

What Is the PHR After Hours Price?

PHR's last after hours stock price is 9.50 USD, the stock has decreased by -0.04, or -0.42%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.